TEVA has BILLIONS of $$$ SPECTRUM Pharma is a PERFECT PLAY to offset Copaxone issues

[Anonymous]

Analysis: TEVA has enjoyed exclusivity for a fantastic product. TEVA has built a team of experts who all have incredible access in the market. SPECTRUM Pharma owns worldwide rights to several incredible products with many years of exclusivity left on their patents. SPECTRUM Pharma lacks depth in all sales channels. SPECTRUM Pharma is a natural acquisition candidate for TEVA. Think about it.

 

[Anonymous]

Re: TEVA has BILLIONS of $$$ SPECTRUM Pharma is a PERFECT PLAY to offset Copaxone is

Analysis: TEVA has enjoyed exclusivity for a fantastic product. TEVA has built a team of experts who all have incredible access in the market. SPECTRUM Pharma owns worldwide rights to several incredible products with many years of exclusivity left on their patents. SPECTRUM Pharma lacks depth in all sales channels. SPECTRUM Pharma is a natural acquisition candidate for TEVA. Think about it.

Analysis: Lay off the crystal meth. Don't think about it and just do it!

 

[Anonymous]

Re: TEVA has BILLIONS of $$$ SPECTRUM Pharma is a PERFECT PLAY to offset Copaxone is

Teva has a salesforce of useless lazy reps who never had to really sell anything because they bought all the doctors and are now trying desperately to get on at Genzyme...

 

[Anonymous]

Re: TEVA has BILLIONS of $$$ SPECTRUM Pharma is a PERFECT PLAY to offset Copaxone is

Yeap lazy Teva reps can't wait to sell Genzymes two blockbuster drugs ....mmm NOT

 

[Anonymous]

Re: TEVA has BILLIONS of $$$ SPECTRUM Pharma is a PERFECT PLAY to offset Copaxone is

Analysis: TEVA has enjoyed exclusivity for a fantastic product. TEVA has built a team of experts who all have incredible access in the market. SPECTRUM Pharma owns worldwide rights to several incredible products with many years of exclusivity left on their patents. SPECTRUM Pharma lacks depth in all sales channels. SPECTRUM Pharma is a natural acquisition candidate for TEVA. Think about it.

"Teva has built a team of experts who all have incredible access in the market".
Or said another way Teva built a team of bag men who understood early on that
Copaxone is the most cumbersome problematic DMT due to its every day inj. How do we get around this? Make the "doctors" more beholden to Teva than they would be to the welfare of their own pts. Pay them and pay them well. And guess what its a great highly successful strategy with neurologists. If other companies paid out what Teva has paid out over the years you'd have "incredible access" as we'll , after all who wants the gravy train to end.
Def:" a fantastic product in the ms neurology market is the result of having more neurologists on your payroll than on the Biogen payroll."
Just thank God this is neurology and not a serious specialty of medicine like oncology or cardiology or any other ology.